Reuters - Video

Edition: U.S. | U.K. | IN | CN

Top News

Wealth Strategies: Biotech stocks at an inflection point

Monday, April 01, 2013 - 04:55

Apr. 1 - Fidelity's Rajiv Kaul, winner of a Lipper Award for 3-year performance, says that while valuations in biotechs can get stretched from time to time, the sector is currently seeing good growth potential

▲ Hide Transcript

View Transcript

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

Wealth Strategies: Biotech stocks at an inflection point

Monday, April 01, 2013 - 04:55